Advisory Services Network, LLC Vericel Corp Transaction History

Advisory Services Network, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$30.85 - $37.09 $6,170 - $7,418	200 New	200 $7,000
Q4 2022 Feb 13, 2023	BUY	$17.65 - $27.37 $3,529 - $5,474	200 New	200 $5,000
Q3 2021 Nov 05, 2021	SELL	$46.35 - $59.75 $9,270 - $11,950	-200 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$47.2 - $67.81 $9,440 - $13,562	200 New	200 $11,000
Q1 2021 May 24, 2021	SELL	$30.93 - $59.48 $6,186 - $11,896	-200 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $156,342 - $203,628	-10,650 Reduced 98.16%	200 $4,000
Q2 2020 Aug 10, 2020	BUY	$8.5 - $15.82 $79,475 - $147,917	9,350 Added 623.33%	10,850 $150,000
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $9,932 - $26,331	1,370 Added 1053.85%	1,500 $14,000
Q4 2019 Feb 04, 2020	SELL	$13.77 - $19.2 $39,519 - $55,104	-2,870 Reduced 95.67%	130 $2,000
Q2 2019 Aug 01, 2019	BUY	$15.01 - $18.89 $22,515 - $28,335	1,500 Added 100.0%	3,000 $0
Q1 2019 May 20, 2019	BUY	$16.23 - $20.29 $22,722 - $28,406	1,400 Added 1400.0%	1,500 $26,000
Q4 2018 Feb 15, 2019	SELL	$10.77 - $18.44 $7,000 - $11,986	-650 Reduced 86.67%	100 $2,000
Q3 2018 Nov 02, 2018	BUY	$9.1 - $14.8 $6,825 - $11,100	750 New	750 $11,000

284

49.2M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.75B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.